Literature DB >> 6320184

Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography.

M R Urist, Y K Huo, A G Brownell, W M Hohl, J Buyske, A Lietze, P Tempst, M Hunkapiller, R J DeLange.   

Abstract

Bovine bone morphogenetic protein (bBMP) induces differentiation of mesenchymal-type cells into cartilage and bone. bBMP has an apparent Mr of 18,500 +/- 500 and represents less than 0.001% of the wet weight of bone tissue. A Mr 34,000 protein resembling osteonectin is separated by extraction with Triton X-100. A Mr 24,000 protein and about half of a Mr 22,000 protein are disassociated from bBMP by precipitation in 1.5 M guanidine hydrochloride. Aggregates of bBMP and a Mr 14,000 protein are insoluble in aqueous media; the bBMP becomes soluble when the Mr 14,000 protein is disassociated in 6 M urea and removed from the solution by ultrafiltration. Three separate molecular species with apparent Mrs 18,500, 17,500, and 17,000 are eluted at 0.10, 0.15, and 0.20 M phosphate ion concentrations, respectively, from a hydroxy-apatite column. The Mr 18,500 protein has the amino acid composition of acidic polylpeptide and includes four half-cystine residues; the pI is 4.9-5.1. The Mr 22,000 component is a chromoprotein resembling ferritin. The NH2-terminal amino acid sequence of the Mr 17,500 protein simulates histone H2B. The Mr 17,000 protein may possess calmodulin activity. Aggregates of the Mr 18,500 and other proteins induce formation of large deposits of bone; the Mr 18,500 protein alone is rapidly absorbed and induces formation of small deposits. None of the other proteins induces bone formation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6320184      PMCID: PMC344678          DOI: 10.1073/pnas.81.2.371

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Solubilized and insolubilized bone morphogenetic protein.

Authors:  M R Urist; A Mikulski; A Lietze
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

2.  Osteonectin, a bone-specific protein linking mineral to collagen.

Authors:  J D Termine; H K Kleinman; S W Whitson; K M Conn; M L McGarvey; G R Martin
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

3.  The nature of bone morphogenetic protein (BMP) fractions derived from bovine bone matrix gelatin.

Authors:  H Mizutani; M R Urist
Journal:  Clin Orthop Relat Res       Date:  1982 Nov-Dec       Impact factor: 4.176

4.  A soluble bone morphogenetic protein extracted from bone matrix with a mixed aqueous and nonaqueous solvent.

Authors:  M R Urist; A J Mikulski
Journal:  Proc Soc Exp Biol Med       Date:  1979-10

5.  Reversible extinction of the morphogen in bone matrix by reduction and oxidation of disulfide bonds.

Authors:  M R Urist; A Mikulski; C N Conteas
Journal:  Calcif Tissue Res       Date:  1975-11-24

6.  A bovine low molecular weight bone morphogenetic protein (BMP) fraction.

Authors:  M R Urist; A Lietze; H Mizutani; K Takagi; J T Triffitt; J Amstutz; R DeLange; J Termine; G A Finerman
Journal:  Clin Orthop Relat Res       Date:  1982 Jan-Feb       Impact factor: 4.176

7.  Bone morphogenesis in implants of insoluble bone gelatin.

Authors:  M R Urist; H Iwata; P L Ceccotti; R L Dorfman; S D Boyd; R M McDowell; C Chien
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

8.  Solubilized bone morphogenetic protein (BMP) from mouse osteosarcoma and rat demineralized bone matrix.

Authors:  H Hanamura; Y Higuchi; M Nakagawa; H Iwata; H Nogami; M R Urist
Journal:  Clin Orthop Relat Res       Date:  1980-05       Impact factor: 4.176

9.  Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone.

Authors:  P A Price; M R Urist; Y Otawara
Journal:  Biochem Biophys Res Commun       Date:  1983-12-28       Impact factor: 3.575

10.  Solubilization and purification of bone morphogenetic protein (BMP) from Dunn osteosarcoma.

Authors:  H Hanamura; Y Higuchi; M Nakagawa; H Iwata; M R Urist
Journal:  Clin Orthop Relat Res       Date:  1980 Nov-Dec       Impact factor: 4.176

View more
  51 in total

1.  Bone morphogenetic protein and ceramic-induced osteogenesis.

Authors:  H Yuan; P Zou; Z Yang; X Zhang; J D De Bruijn; K De Groot
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

Review 2.  Growth factors and the skeletal system.

Authors:  E Canalis; T L McCarthy; M Centrella
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

3.  Multifocal osteoma cutis in a golden retriever.

Authors:  Dawn M Martin; Jan Hall; Natalie Keirstead; Andrew Lowe
Journal:  Can Vet J       Date:  2006-04       Impact factor: 1.008

4.  Effects of a new allograft processing procedure on graft healing in a canine model: a preliminary study.

Authors:  Kathleen S Beebe; Joseph Benevenia; Benjamin E Tuy; C Alex DePaula; Robert D Harten; William F Enneking
Journal:  Clin Orthop Relat Res       Date:  2008-08-19       Impact factor: 4.176

5.  50 years ago in CORR: Physiologic basis of bone-graft surgery Marshall R. Urist MD CORR 1953;1:207-216.

Authors:  Richard A Brand
Journal:  Clin Orthop Relat Res       Date:  2008-06-03       Impact factor: 4.176

6.  Free vascularised fibular grafting with OsteoSet®2 demineralised bone matrix versus autograft for large osteonecrotic lesions of the femoral head.

Authors:  Yong Feng; Shanzhi Wang; Dongxu Jin; Jiagen Sheng; Shengbao Chen; Xiangguo Cheng; Changqing Zhang
Journal:  Int Orthop       Date:  2009-12-09       Impact factor: 3.075

Review 7.  Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors.

Authors:  Kyung Bo Kim; Craig M Crews
Journal:  J Med Chem       Date:  2008-04-05       Impact factor: 7.446

8.  The clinical application of human bone matrix gelatin.

Authors:  F Li; T Y Wang; R Y Xia; R Z Ma
Journal:  J Tongji Med Univ       Date:  1995

9.  Trends analysis of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States.

Authors:  Lifeng Lao; Jeremiah R Cohen; Elizabeth L Lord; Zorica Buser; Jeffrey C Wang
Journal:  Eur Spine J       Date:  2015-05-24       Impact factor: 3.134

10.  Effect of scaffold microarchitecture on osteogenic differentiation of human mesenchymal stem cells.

Authors:  Ameya Phadke; YongSung Hwang; Su Hee Kim; Soo Hyun Kim; Tomonori Yamaguchi; Koichi Masuda; Shyni Varghese
Journal:  Eur Cell Mater       Date:  2013-01-18       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.